Physician profile
Mark Julius Florian
NPI 1396768347
$10,273.34
in general payments reported to CMS, 2019-2025
48 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $1,960 · 2021: $2,104 · 2022: $1,427 · 2023: $887 · 2024: $969 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,587.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $845.90 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $688.69 | 2019-2025 | |
| Abbvie INC. | $629.28 | 2019-2024 | |
| Lilly USA, LLC | $462.28 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $437.60 | 2019-2023 | Spravato |
| Sanofi-Aventis U.S. LLC | $418.27 | 2019-2023 | |
| Astellas Pharma US INC | $402.24 | 2019-2022 | |
| Amarin Pharma, INC. | $379.34 | 2019-2022 | |
| Exact Sciences Corporation | $379.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $368.68 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.97 | 2019-2025 | Jardiance |
| Amgen INC. | $299.04 | 2019-2024 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $280.82 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $203.92 | 2019-2023 | Steglatro, Belsomra |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Florian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.